Second Quarter 2025 Results Key Financial Results Revenue: US$483.4m (up 4.3% from ...

Second Quarter 2025 Results Key Financial Results Revenue: US$185.5m (up 28% from ...

Key Points Earnings per share (Non-GAAP) were $0.94 in Q2 2025 beating the analyst estimate by 9.3% (non-GAAP) and the company exceeded its non-GAAP EPS outlook by $0.08. Net sales (GAAP) reached ...

Key Points Non-GAAP EPS rose to $0.64, beating the $0.53 non-GAAP estimate and up 42.2% year over year for ENI diluted earnings per share (non-GAAP). Net inflows set a firm record at $13.8 billion, ...

Q2 2025 Earnings Call Transcript August 1, 2025 Fortis Inc. beats earnings expectations. Reported EPS is $0.558, expectations ...

Regeneron develops, manufactures, and markets medicines for serious diseases with a primary focus on immunology, ophthalmology, oncology, and rare conditions. Its scientific model centers on a robust ...

Q2 2025 Earnings Call Transcript August 1, 2025 Ingredion Incorporated beats earnings expectations. Reported EPS is $2.87, ...

If any investor has stood the test of time, it’s Warren Buffett, and with good reason. For years, the “Oracle of Omaha” has ...

Praxis Precision Medicine PRAX -4.09% Get Free Report will release its quarterly earnings report on Monday, 2025-08-04. Here's a brief overview for investors ahead of the announcement. Analysts ...

Consider selling overvalued United Breweries Ltd stock due to stretched valuations, limited pricing power, and modest margins ...

But there is a non-statistical basis for concern: an ominous parallel with the financial environment that prevailed in the weeks leading up to the October 1987 stock-market crash. On that day - Black ...

Operator: Hello, and thank you for standing by. My name is Bella, and I will be your conference operator today.